Abstract
Objective
Vitamin E and selenium are promising nutrients for the prevention of prostate cancer, and both are currently being tested in a large randomized trial for prostate cancer. However, results are not expected for at least 6 years.
We aimed to investigate the association of vitamin E and selenium supplementation with prostate cancer in the VITamins And Lifestyle (VITAL) study, a cohort study specifically designed to examine supplement use and future cancer risk.
Methods
In a prospective design, 35,242 men recruited between 2000 and 2002 from western Washington State completed a questionnaire, including detailed questions about vitamin E and selenium supplement intake during the past 10 years from brand-specific multivitamins and single supplements. Using linkage to the western Washington SEER cancer registry, we documented 830 new cases of prostate cancer from baseline through December 2004.
Results
A 10-year average intake of supplemental vitamin E was not associated with a reduced prostate cancer risk overall [hazard ratio (HR) 0.86, 95% confidence interval (CI) 0.65–1.1 for ≥400 IU/day vs. non-use, p for trend 0.36]; however, risk for advanced prostate cancer (regionally invasive or distant metastatic, n = 123) decreased significantly with greater intake of supplemental vitamin E (HR 0.43, 95% CI 0.19–1.0 for 10-year average intake ≥400 IU/day vs. non-use, p for trend 0.03). There was no association between selenium supplementation and prostate cancer risk (HR 0.90, 95% CI 0.62–1.3 for 10-year average intake >50 μg/day vs. non-use, p for trend 0.97).
Conclusions
In this prospective cohort, long-term supplemental intake of vitamin E and selenium were not associated with prostate cancer risk overall; however, risk of clinically relevant advanced disease was reduced with greater long-term vitamin E supplementation.
Similar content being viewed by others
Abbreviations
- CI:
-
Confidence interval
- OR:
-
Odds ratio
- VITAL cohort:
-
Vitamins and lifestyle cohort
References
Klein EA, Thompson IM, Lippman SM et al (2001) SELECT: the next prostate cancer prevention trial. Selenium and vitamin E cancer prevention trial. J Urol 166:1311–5
Klein EA, Thompson IM, Lippman SM et al (2003) SELECT: the selenium and vitamin E cancer prevention trial. Urol Oncol 21:59–65
Klein EA, Thompson IM, Lippman SM et al (2001) SELECT: the next prostate cancer prevention trial. Selenium and Vitamin E cancer prevention trial. J Urol 166:1311–1315
Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG (1973) Selenium: biochemical role as a component of glutathione peroxidase. Science 179:588–590
Combs GF Jr, Gray WP (1998) Chemopreventive agents: selenium. Pharmacol Ther 79:179–192
Ripple MO, Henry WF, Rago RP, Wilding G (1997) Prooxidant-antioxidant shift induced by androgen treatment of human prostate carcinoma cells. J Natl Cancer Inst 89:40–48
Iynem AH, Alademir AZ, Obek C, Kural AR, Konukoglu D, Akcay T (2004) The effect of prostate cancer and antiandrogenic therapy on lipid peroxidation and antioxidant systems. Int Urol Nephrol 36:57–62
Tam NN, Gao Y, Leung YK, Ho SM (2003) Androgenic regulation of oxidative stress in the rat prostate: involvement of NAD(P)H oxidases and antioxidant defense machinery during prostatic involution and regrowth. Am J Pathol 163:2513–2522
Fleshner NE, Klotz LH (1998) Diet, androgens, oxidative stress and prostate cancer susceptibility. Cancer Metastasis Rev 17:325–330
Tapiero H, Townsend DM, Tew KD (2003) The antioxidant role of selenium and seleno-compounds. Biomed Pharmacother 57:134–44
Loft S, Poulsen HE (1996) Cancer risk and oxidative DNA damage in man. J Mol Med 74:297–312
Dial S, Eitenmiller RR (1995) Tocopherols and tocotrienols in key foods in the U.S. diet. In: Ong ASH, Niki E, Packer L (eds) Nutrition, lipids, health, and disease. AOCS Press, Champaign, IL, pp 327–342
McLaughlin PJ, Weihrauch JL (1979) Vitamin E content of foods. J Am Diet Assoc 75:647–665
Institute of Medicine I (2000) Dietary reference intakes for vitamin C, vitamin E, selenium, and carotenoids. Washington, DC: National Academy Press
Blatt DH, Leonard SW, Traber MG (2001) Vitamin E kinetics and the function of tocopherol regulatory proteins. Nutrition 17:799–805
Traber MG, Kayden HJ (1989) Preferential incorporation of alpha-tocopherol vs gamma- tocopherol in human lipoproteins. Am J Clin Nutr 49:517–526
Heinonen OP, Albanes D, Virtamo J et al (1998) Prostate cancer and supplementation with alpha-tocopherol and beta- carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 90:440–446
Lonn E, Bosch J, Yusuf S et al (2005) Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 293:1338–1347
Schwarz K, Foltz C (1957) J Am Chem Soc 79, 3292
Grossman JN, Grosz AE, Schweitzer PN, Schruben PN (2005) The National Geochemical Survey Team . The National Geochemical Survey–Database and Documentation. U.S. Geological Survey Open-File Report 2004–1001. http://tin.er.usgs.gov/geochem/doc/averages/se/usa.html
Kubota J, Allaway WH, Carter DL, Cary EE, Lazar VA et al (1967) Selenium in crops in the United States in relation to selenium-responsive diseases of animals. J Agric Food Chem 15:448
Levander OA (1985) Considerations on the assessment of selenium status. Fed Proc 44:2579–2583
Holden J, Gebhardt R, Davis C, Lurie D (1991) A nationwide study of the selenium content and variability in white bread. J Food Compost Anal 4:183–195
Clark LC, Combs GF Jr, Turnbull BW et al (1996) Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional prevention of cancer study group. JAMA 276:1957–1963
Duffield-Lillico AJ, Reid ME, Turnbull BW et al (2002) Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: a summary report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol Biomarkers Prev 11:630–639
Clark LC, Dalkin B, Krongrad A et al (1998) Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br J Urol 81:730–734
Hill KE, Xia Y, Akesson B, Boeglin ME, Burk RF (1996) Selenoprotein P concentration in plasma is an index of selenium status in selenium-deficient and selenium-supplemented Chinese subjects. J Nutr 126:138–145
Neve J (1995) Human selenium supplementation as assessed by changes in blood selenium concentration and glutathione peroxidase activity. J Trace Elem Med Biol 9:65–73
Longnecker MP, Taylor PR, Levander OA et al (1991) Selenium in diet, blood, and toenails in relation to human health in a seleniferous area. Am J Clin Nutr 53:1288–1294
Hunter DJ, Morris JS, Chute CG et al (1990) Predictors of selenium concentration in human toenails. Am J Epidemiol 132:114–122
Pennington JA, Young BE, Wilson DB (1989) Nutritional elements in U.S. diets: results from the Total diet study, 1982 to 1986. J Am Diet Assoc 89:659–664
White E, Patterson RE, Kristal AR et al (2004) VITamins And Lifestyle cohort study: study design and characteristics of supplement users. Am J Epidemiol 159:83–93
Patterson RE, Kristal AR, Levy L, McLerran D, White E (1998) Validity of methods used to assess vitamin and mineral supplement use. Am J Epidemiol 148:643–649
Patterson RE, Neuhouser ML, White E, Kristal AR, Potter JD (1998) Measurement error from assessing use of vitamin supplements at one point in time. Epidemiology 9:567–569
Patterson RE, Levy L, Tinker LF, Kristal AR (1999) Evaluation of a simplified vitamin supplement inventory developed for the Women’s Health Initiative. Public Health Nutr 2:273–276
Medical Economics Staff (2002) Physicians Desk Reference for Nonprescription Drugs and Dietary Supplements. Medical Economics, Montvale
Satia-Abouta J, Patterson RE, King IB et al (2003) Reliability and validity of self-report of vitamin and mineral supplement use in the vitamins and lifestyle study. Am J Epidemiol 157:944–954
Satia JA, King IB, Morris JS, Stratton K, White E (2005) Toenail and Plasma Levels as Biomarkers of Selenium Exposure. Ann Epidemiol
Kristal AR, Feng Z, Coates RJ, Oberman A, George V (1997) Associations of race/ethnicity, education, and dietary intervention with the validity and reliability of a food frequency questionnaire: the Women’s Health Trial Feasibility Study in Minority Populations. Am J Epidemiol 146:856–869
Patterson RE, Kristal AR, Tinker LF, Carter RA, Bolton MP, Agurs-Collins T (1999) Measurement characteristics of the Women’s Health Initiative food frequency questionnaire. Ann Epidemiol 9:178–187
Schakel SF, Buzzard IM, Gebhardt SE (1997) Procedures for estimating nutrient values for food composition databases. J Food Compost Anal 10:102–114
Korn EL, Graubard BI, Midthune D (1997) Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 145:72–80
Hosmer DW, Lemeshow S (1999) Applied survival analysis: regression modeling of time to event data. Wiley series in probability and statistics. Texts and references section. Wiley, New York
Church DF, Pryor WA (1985) Free-radical chemistry of cigarette smoke and its toxicological implications. Environ Health Perspect 64:111–126
Frei B, Forte TM, Ames BN, Cross CE (1991) Gas phase oxidants of cigarette smoke induce lipid peroxidation and changes in lipoprotein properties in human blood plasma. Protective effects of ascorbic acid. Biochem J 277(Pt 1):133–138
Pryor WA, Hales BJ, Premovic PI, Church DF (1983) The radicals in cigarette tar: their nature and suggested physiological implications. Science 220:425–427
Shibata A, Paganini-Hill A, Ross RK, Henderson BE (1992) Intake of vegetables, fruits, beta-carotene, vitamin C and vitamin supplements and cancer incidence among the elderly: a prospective study. Br J Cancer 66:673–679
Chan JM, Stampfer MJ, Ma J, Rimm EB, Willett WC, Giovannucci EL (1999) Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States. Cancer Epidemiol Biomarkers Prev 8:893–899
Schuurman AG, Goldbohm RA, Brants HA, Van den Brandt PA (2002) A prospective cohort study on intake of retinol, vitamins C and E, and carotenoids and prostate cancer risk (Netherlands). Cancer Causes Control 13:573–582
Kirsh VA, Hayes RB, Mayne ST et al (2006) Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst 98:245–254
Rodriguez C, Jacobs EJ, Mondul AM, Calle EE, McCullough ML, Thun MJ (2004) Vitamin E supplements and risk of prostate cancer in U.S. men. Cancer Epidemiol Biomarkers Prev 13:378–382
Miller ER III, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E (2005) Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 142:37–46
Gann PH, Ma J, Giovannucci E et al (1999) Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res 59:1225–1230
Hsing AW, Comstock GW, Abbey H, Polk BF (1990) Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of prostate cancer. J Natl Cancer Inst 82:941–946
Nomura AM, Stemmermann GN, Lee J, Craft NE (1997) Serum micronutrients and prostate cancer in Japanese Americans in Hawaii. Cancer Epidemiol Biomarkers Prev 6:487–491
Goodman GE, Schaffer S, Omenn GS, Chen C, King I (2003) The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial. Cancer Epidemiol Biomarkers Prev 12:518–526
Helzlsouer KJ, Huang HY, Alberg AJ et al (2000) Association between alpha-tocopherol, gamma-tocopherol, selenium, and subsequent prostate cancer. J Natl Cancer Inst 92:2018–2023
Huang HY, Alberg AJ, Norkus EP, Hoffman SC, Comstock GW, Helzlsouer KJ (2003) Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am J Epidemiol 157:335–344
Weinstein SJ, Wright ME, Pietinen P et al (2005) Serum alpha-tocopherol and gamma-tocopherol in relation to prostate cancer risk in a prospective study. J Natl Cancer Inst 97:396–9
Knekt P, Aromaa A, Maatela J et al (1988) Serum vitamin E and risk of cancer among Finnish men during a 10-year follow-up. Am J of Epidemiol 127(2): 28–41
Hartman TJ, Albanes D, Pietinen P et al (1998) The association between baseline vitamin E, selenium, and prostate cancer in the alpha-tocopherol, beta-carotene cancer prevention study. Cancer Epidemiol Biomarkers Prev 7:335–340
Eichholzer M, Stahelin HB, Ludin E, Bernasconi F (1999) Smoking, plasma vitamins C, E, retinol, and carotene, and fatal prostate cancer: seventeen-year follow-up of the prospective basel study. Prostate 38:189–198
Bieri JG, Corash L, Hubbard VS (1983) Medical uses of vitamin E. N Engl J Med 308(18): 1063–1071
Burton GW, Ingold KU (1981) Autoxidation of biological molecules. 1. The antioxidant activity of vitamin E and related chain-breaking phenolic antioxidants in vitro. J Am Chem Soc 103:6472
Ni J, Wen X, Yao J et al (2005) Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway. Cancer Res 65:9807–9816
Israel K, Yu W, Sanders BG, Kline K (2000) Vitamin E succinate induces apoptosis in human prostate cancer cells: role for Fas in vitamin E succinate-triggered apoptosis. Nutr Cancer 36:90–100
Malafa MP, Fokum FD, Andoh J et al (2006) Vitamin E succinate suppresses prostate tumor growth by inducing apoptosis. Int J Cancer 118:2441–2447
Mahoney CW, Azzi A (1988) Vitamin E inhibits protein kinase C activity. Biochem Biophys Res Commun 154:694–697
Venkateswaran V, Fleshner NE, Klotz LH (2002) Modulation of cell proliferation and cell cycle regulators by vitamin E in human prostate carcinoma cell lines. J Urol 168:1578–1582
Yu A, Somasundar P, Balsubramaniam A, Rose AT, Vona-Davis L, McFadden DW (2002) Vitamin E and the Y4 agonist BA-129 decrease prostate cancer growth and production of vascular endothelial growth factor. J Surg Res 105:65–8
Zhang M, Altuwaijri S, Yeh S (2004) RRR-alpha-tocopheryl succinate inhibits human prostate cancer cell invasiveness. Oncogene 23:3080–3088
Zhang Y, Ni J, Messing EM, Chang E, Yang CR, Yeh S (2002) Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells. Proc Natl Acad Sci USA 99:7408–7413
Li H, Stampfer MJ, Giovannucci EL et al (2004) A prospective study of plasma selenium levels and prostate cancer risk. J Natl Cancer Inst 96:696–703
Van den Brandt PA, Zeegers MP, Bode P, Goldbohm RA (2003) Toenail selenium levels and the subsequent risk of prostate cancer: a prospective cohort study. Cancer Epidemiol Biomarkers Prev 12:866–871
Nomura AM, Lee J, Stemmermann GN, Combs GF Jr (2000) Serum selenium and subsequent risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 9:883–887
Yoshizawa K, Willett WC, Morris SJ et al (1998) Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer. J Natl Cancer Inst 90:1219–1224
Brooks JD, Metter EJ, Chan DW et al (2001) Plasma selenium level before diagnosis and the risk of prostate cancer development. J Urol 166:2034–2038
Vogt TM, Ziegler RG, Graubard BI et al (2003) Serum selenium and risk of prostate cancer in U.S. blacks and whites. Int J Cancer 103:664–670
Goodman GE, Schaffer S, Bankson DD, Hughes MP, Omenn GS (2001) Predictors of serum selenium in cigarette smokers and the lack of association with lung and prostate cancer risk. Cancer Epidemiol Biomarkers Prev 10:1069–1076
Knekt P, Aromaa A, Maatela J et al (1990) Serum selenium and subsequent risk of cancer among Finnish men and women. J Natl Cancer Inst 82:864–868
Allen NE, Morris JS, Ngwenyama RA, Key TJ (2004) A case–control study of selenium in nails and prostate cancer risk in British men. Br J Cancer 90:1392–1396
Ghadirian P, Maisonneuve P, Perret C et al (2000) A case-control study of toenail selenium and cancer of the breast, colon, and prostate. Cancer Detect Prev 24:305–3013
Peters U, Foster CB, Chatterjee N et al (2007) Serum selenium and risk of prostate cancer-a nested case-control study. Am J Clin Nutr 85:209–217
Acknowledgments
We thank the participants of the Vitamins and Lifestyle study for their support. All authors were responsible for the study concept and design, and participated in writing the manuscript. AJL analyzed the data and UP drafted the manuscript. None of the authors had a personal or financial conflict of interest. Grant support: Supported by grant R01 CA74846, the Career Development grant K22 CA118421 and the Cancer Prevention training grant R25T CA94880 from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Peters, U., Littman, A.J., Kristal, A.R. et al. Vitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and lifestyle (VITAL) study cohort. Cancer Causes Control 19, 75–87 (2008). https://doi.org/10.1007/s10552-007-9072-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-007-9072-y